Ekblom A, Westman L, Söderlund A, Valentin A, Eriksson E
Department of Anaesthesiology and Intensive Care, Karolinska Hospital, Stockholm, Sweden.
Knee Surg Sports Traumatol Arthrosc. 1993;1(3-4):189-94. doi: 10.1007/BF01560204.
We investigated the per- and postoperative pain-reducing effect of pethidine given intra-articularly (i. art.). Thirty patients subjected to knee joint arthroscopy, diagnostic and surgical procedures, were randomly assigned to one of three groups. Group A consisted of ten patients who received 250 mg prilocaine + 200 micrograms adrenaline (i. art.) in a volume of 50 ml, group B of ten patients who received 200 mg pethidine (i. art.) in 50 ml saline, and group C of ten patients who received 200 mg pethidine + 200 micrograms adrenaline (i. art.) in 50 ml saline. During arthroscopy the patients reported on pain intensity and discomfort using visual analogue scales. Ratings were low and did not differ significantly between the three groups. Two of three patients in each group requested additional analgesics or sedatives due to pain and discomfort, but again with no difference between the three groups. Postoperatively all patients rated their pain intensity at rest and during movement (at 0, 1, 2, 3, 4, 5, 6, 12 and 24 h). The patients receiving pethidine (group B) reported significantly less pain at rest and movement than group A patients, in general at 1-4 h postoperatively. A significant difference was detected between groups B and C at 4 h postoperatively. Calculating the total sum of pain scores, patients receiving pethidine (group B) reported significantly less pain both at rest and during movement than those receiving prilocaine (group A). Furthermore, patients in group B used significantly less analgesics than those in group A. Adrenaline did not potentiate the effect of pethidine.(ABSTRACT TRUNCATED AT 250 WORDS)
我们研究了关节腔内注射哌替啶在术前和术后的镇痛效果。30例接受膝关节镜检查、诊断和手术操作的患者被随机分为三组。A组10例患者接受250mg丙胺卡因+200μg肾上腺素关节腔内注射(50ml);B组10例患者接受200mg哌替啶关节腔内注射(50ml生理盐水);C组10例患者接受200mg哌替啶+200μg肾上腺素关节腔内注射(50ml生理盐水)。在关节镜检查期间,患者使用视觉模拟量表报告疼痛强度和不适程度。评分较低,三组之间无显著差异。每组中有三分之二的患者因疼痛和不适要求额外的镇痛药或镇静剂,但三组之间仍无差异。术后所有患者对静息和活动时的疼痛强度进行评分(0、1、2、3、4、5、6、12和24小时)。接受哌替啶的患者(B组)在静息和活动时的疼痛报告明显少于A组患者,一般在术后1-4小时。术后4小时,B组和C组之间检测到显著差异。计算疼痛评分总和,接受哌替啶的患者(B组)在静息和活动时的疼痛报告明显少于接受丙胺卡因的患者(A组)。此外,B组患者使用的镇痛药明显少于A组。肾上腺素并未增强哌替啶的效果。(摘要截断于250字)